Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2021 11:00 ET | Source: CDx Diagnostics

WATS3D Receives Medically Necessary Designation from Blue Cross Blue Shield of Kansas City

SUFFERN, N.Y., March 09, 2021 (GLOBE NEWSWIRE) -- WATS3D, a diagnostic platform used by physicians to detect Barrett’s esophagus (BE), pre-cancer and cancerous cells in the esophagus, has received a...
January 26, 2021 14:00 ET | Source: CDx Diagnostics

WATS3D Now Considered Medically Necessary by BlueCross BlueShield of South Carolina

SUFFERN, N.Y., Jan. 26, 2021 (GLOBE NEWSWIRE) -- WATS3D, an AI-powered diagnostic platform developed by CDx Diagnostics to identify precancerous and cancerous cells in the esophagus, is now...
December 15, 2020 11:30 ET | Source: CDx Diagnostics

CDx Diagnostics Awarded Federal Supply Schedule Contract

Veterans now have access to WATS3D life-saving technology in the VA and community settings SUFFERN, N.Y., Dec. 15, 2020 (GLOBE NEWSWIRE) -- CDx Diagnostics has been awarded GSA Contract...
August 25, 2020 13:00 ET | Source: CDx Diagnostics

Study Confirms WATS3D as Cost-Effective Adjunct to Seattle Protocol

The addition of WATS3D to the screening process for BE resulted in approximately 3 fewer cancers and 3 fewer cancer deaths per 1,000 people screened SUFFERN, N.Y., Aug. 25, 2020 (GLOBE NEWSWIRE) --...
June 16, 2020 13:00 ET | Source: CDx Diagnostics

SAGES TAVAC Analysis Indicates WATS3D is a Safe and Effective Diagnostic Technique for Barrett’s Esophagus

SUFFERN, N.Y., June 16, 2020 (GLOBE NEWSWIRE) -- WATS3D, an AI-powered diagnostic platform used to identify precancerous cells in the esophagus, has been deemed as a safe and effective adjunctive to...